FindTrial
Sign In

Study of Use of a hormone - Parathyroid hormone to predict reduced calcium levels after complete removal of thyroid gland surgery in the early postoperative period

Intact Parathyroid hormone levels in predicting postoperative hypocalcaemia after total thyroidectomy - Cross sectional study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/07/009149
Enrollment
70
Registered
2017-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Post Total thyroidectomy patients

Interventions

None listed

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients undergoing total thyroidectomy for both benign and malignant thyroid disorders

Exclusion criteria

Exclusion criteria: Hypothyroidism,hyperthyroidism ,hypoalbuminemia , renal dysfunction

Design outcomes

Primary

MeasureTime frame
To assess if intact parathyroid hormone measurement 1 hour after surgery is a reliable indicator of hypocalcaemia in the early postoperative period .Timepoint: To assess if intact parathyroid hormone measurement 1 hour after surgery is a reliable indicator of hypocalcaemia in the early postoperative period .—

Secondary

MeasureTime frame
Prevention and treatment of hypocalcaemiaTimepoint: 1 week—

Countries

India

Contacts

Public ContactManu C B

JIPMER

saxenasunil.jipmer@gmail.com9940957050

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026